EDGAR Filing Documents for 0001193125-14-313479

Form 8-K - Current report:

SEC Accession No. 0001193125-14-313479

Filing Date

2014-08-18

Accepted

2014-08-18 17:16:59

Documents

Period of Report

2014-08-12

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d775802d8k.htm	8-K	31742
2	EX-4.1	d775802dex41.htm	EX-4.1	537594
3	EX-10.1	d775802dex101.htm	EX-10.1	132105
4	EX-10.2	d775802dex102.htm	EX-10.2	132329
5	EX-10.3	d775802dex103.htm	EX-10.3	153406
6	EX-10.4	d775802dex104.htm	EX-10.4	155677
7	EX-10.5	d775802dex105.htm	EX-10.5	137279
8	EX-10.6	d775802dex106.htm	EX-10.6	132050
9	EX-10.7	d775802dex107.htm	EX-10.7	153704
10	EX-10.8	d775802dex108.htm	EX-10.8	150005
	Complete submission text file	0001193125-14-313479.txt		1717239

Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037

Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500

LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)